Navigation Links
Digital mammography system developed at Mass General Hospital receives FDA approval
Date:9/3/2014

BOSTON A digital mammography system developed based on concepts originally tested at Massachusetts General Hospital (MGH) has been approved by the U.S. Food and Drug Administration. GE Healthcare received approval to market the SenoClaire* Digital Breast Tomosynthesis system, which is based on patented technology licensed from the MGH and developed under the leadership of Daniel B. Kopans, MD, founder and senior radiologist in the Breast Imaging Division of the MGH Department of Radiology.

Soon after wide-spread screening mammography was introduced in the mid-1980s, Kopans notes, U.S. death rates from breast cancer which had remained unchanged for more than 40 years began to decline. But the limitations of conventional mammography reduce its ability to find all tumors while avoiding false positive readings. "A conventional mammogram presents the radiologist with an image that is like a book with transparent pages," he explains. "You can hold that book up to the light and look through it, but the words are superimposed on each other, providing an image that can be confusing. Sometimes cancers can be hidden by normal tissues, and at other times normal tissues superimposed on top of each other give the false appearance of a tumor, requiring patients to be recalled for further screening."

Kopans originally proposed applying a theoretical technique called tomosynthesis construction of a 3D image from digital readings taken at many different tissue depths to the problem of superimposition in 1978, but the digital image detectors and powerful computers required to construct such images were not available until the 1990s. The device developed by Kopans and his team including Richard Moore, director of Breast Imaging Research allows radiologists to page through the mammographic "book" one page at a time. Clinical trials have shown this elimination of tissue superimposition can reveal tumors hidden on conventional mammograms and reduces false positive readings.

"This is an exciting time in breast imaging," says Kopans, who is a professor of Radiology at Harvard Medical School. "Conventional mammography, even with its limitations, has helped to dramatically reduce deaths from breast cancer. The availability of digital breast tomosynthesis should help to drive breast cancer deaths down even further, and this FDA approval should make the technology available to more and more woman. We all hope for ways to totally prevent or cure breast cancer, but until such methods are available, we will continue working to find more ways to detect breast cancer earlier to save the lives of patients with breast cancer."


'/>"/>

Contact: Katie Marquedant
KMarquedant@partners.org
617-726-0337
Massachusetts General Hospital
Source:Eurekalert

Related medicine news :

1. Digital breast tomosynthesis cuts recall rates by 40 percent
2. VisionWare and Serco Partner to Enable ‘Digital by Default’ Strategy
3. Digital tablets improve speed and ease of reading for people with moderate vision loss
4. A Media Representative for Dr. Castro Announces New Updates on the Dental Implants Specialist in Rancho Cucamonga's Website with Information on Digital X-Rays
5. Visiopharm Acquires Digital Pathology Consultants
6. Exack LLC Announced Today the Launch of its New High Quality Digital Micro Voice Recorder, MemClick
7. Life’s Eyes Media Offering Digital Military Christmas Greetings Videos
8. Digital Living Room Market is Growing at CAGR of 2.55% to Reach $217.58 Billion by 2018, Says New Report by MarketsandMarkets
9. Show Me the Money: Living in Digital Times presents Investing in the Sports & Fitness Industry
10. Digital diagnostic tools lead to patient dissatisfaction, says MU expert
11. Capsule Endoscopy (Smart/Digital Pills) Market is expected to grow at a CAGR of 17% & to reach $965 Million by 2017 - by MarketsandMarkets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/6/2016)... Albuquerque, NM (PRWEB) , ... December 06, 2016 ... ... awarded JumpStart Autism Center with an Award of Distinction, recognizing the organization as ... needs providers that excel in the areas of clinical quality, staff satisfaction and ...
(Date:12/6/2016)... ... December 06, 2016 , ... Gateway Analytical, ... offering HIAC particle counting and sizing services for USP 788 and 789 particulate ... new service as a response to the needs of pharmaceutical and medical device ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... November 25th, when SevenPoint2 released the much-anticipated HydroFX for Water®. This first-of-its-kind ... design. Featuring one of the world’s most powerful antioxidants, molecular hydrogen, HydroFX ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... of the newly updated International Audit Protocol Consortium (IAPC) EHS audit protocol for ... protocols to understand the scope of their EHS regulatory obligations and rapidly collect, ...
(Date:12/6/2016)... Georgia (PRWEB) , ... December 06, 2016 , ... ... consecutive year to "Training" magazine’s 2017 Training Top 125 for their industry leading ... This prestigious, annual award recognizes USA as among the global elite in employer-sponsored ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... , Dec. 6, 2016 /PRNewswire/ - InMed Pharmaceuticals, ... today on its R&D program in the use ... pulmonary disease (COPD). In June, 2015 InMed initiated ... to identify the targets and potential active compounds ... COPD. Subsequently, with in vitro assays using human ...
(Date:12/5/2016)... WARSAW, Ind. , Dec. 5, 2016  Zimmer ... "Company") today announced that, pursuant to its previously-announced ... securities identified in the table below (collectively, the ... Notes were validly tendered and not validly withdrawn ... York City time, today, December 5, ...
(Date:12/5/2016)... 5, 2016 Sangamo BioSciences, Inc. (Nasdaq: ... presentation of preclinical and manufacturing data that support SB-525, its ... Annual Meeting of the American Society of Hematology (ASH) ... from December 3-6, 2016. "We have developed an ... we believe is highly competitive, and we remain on track ...
Breaking Medicine Technology: